Joseph Klein III

Joseph Klein III has an estimated net worth of $15.7 Million. This is based on reported shares across multiple companies, which include GENAISSANCE PHARMACEUTICALS INC, SAVIENT PHARMACEUTICALS INC, BIOMARIN PHARMACEUTICAL INC, IONIS PHARMACEUTICALS INC, AKCEA THERAPEUTICS, INC., NPS PHARMACEUTICALS INC, PDL BIOPHARMA, INC., CLINICAL DATA INC, OSI PHARMACEUTICALS INC, and GUILFORD PHARMACEUTICALS INC.

2007 was Joseph Klein III's most active year for acquiring shares with 41 total transactions. Joseph Klein III's most active month to acquire stocks was the month of June. 2008 was Joseph Klein III's most active year for disposing of shares, totalling 63 transactions. Joseph Klein III's most active month to dispose stocks was the month of February. 2026 saw Joseph Klein III paying a total of $2,009,155.89 for 48,432 shares, this is the most they've acquired in one year. In 2025 Joseph Klein III cashed out on 136,000 shares for a total of $4,320,000.00, their largest year based on trade value.